0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Guillain-Barre Syndrome (GBS) -Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-229
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Guillain Barre Syndrome Epidemiology Forecast to 2028

Guillain-Barre Syndrome (GBS) -Epidemiology Forecast to 2028

Code: DELV-Epid-229
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Guillain-Barre Syndrome (GBS) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Guillain-Barre Syndrome (GBS) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Guillain-Barre Syndrome (GBS) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Guillain-Barre Syndrome (GBS) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Guillain-Barre Syndrome (GBS) outlook. It also includes the explanation of changing trends of epidemiology outlining the Guillain-Barre Syndrome (GBS) scenario.

Guillain-Barre Syndrome (GBS) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Guillain-Barre Syndrome (GBS) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Guillain-Barre Syndrome (GBS) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Guillain-Barre Syndrome (GBS) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Guillain-Barre Syndrome (GBS)

Key assessments
• Patient Segmentation in Guillain-Barre Syndrome (GBS)
• Guillain-Barre Syndrome (GBS) Risk & Burden
• Factors driving growth in a specific Guillain-Barre Syndrome (GBS) patient population

1. Report Introduction
2. Guillain-Barre Syndrome (GBS) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Guillain-Barre Syndrome (GBS) in 2016
2.2. Patient Share Distribution of Guillain-Barre Syndrome (GBS) in 2028
3. Disease Background and Overview: Guillain-Barre Syndrome (GBS)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Guillain-Barre Syndrome (GBS) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Guillain-Barre Syndrome (GBS) in 7MM – By Countries
5. Epidemiology of Guillain-Barre Syndrome (GBS) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.1.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) *
5.1.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.1.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.4.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS)*
5.4.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.4.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.5.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS)*
5.5.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.5.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.6.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS)*
5.6.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.6.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.7.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS)*
5.7.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.7.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.8.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS)*
5.8.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.8.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS)
5.9.3. Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS)*
5.9.4. Sex- Specific Cases of the Guillain-Barre Syndrome (GBS)*
5.9.5. Diagnosed Cases of the Guillain-Barre Syndrome (GBS)
6. Unmet Needs of the Guillain-Barre Syndrome (GBS)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in 7MM
Table 2: Total Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028) *
Table 14: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Guillain-Barre Syndrome (GBS) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report Forecast 2021 2027
China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6U7133
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Attention Deficit Hyperactivity Disorder ADHD Market Report Forecast 2021 2027
China Attention Deficit Hyperactivity Disorder (ADHD) Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21N5737
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Autism Spectrum Disorder Market Report Forecast 2021 2027
China Autism Spectrum Disorder Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-1I362
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Neurodegenerative Disease Market Size Status and Forecast 2021 2027
Global and United States Neurodegenerative Disease Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-16X6731
Sat Sep 04 00:00:00 UTC 2021

Add to Cart